Conference Proceedings

PATTERNS AND PREVALENCE OF IMMUNE-RELATED ADVERSE EVENTS AS DETECTED WITH FDG PET/CT IN PATIENTS TREATED WITH COMBINED CTLA-4 AND PD-1 INHIBITOR AS FIRST-LINE THERAPY FOR ADVANCED MELANOMA

A Iravani, MM Osman, MS Hofman, A Weppler, G Au-Yeung, S Sandhu, RJ Hicks

INTERNAL MEDICINE JOURNAL | WILEY | Published : 2019